BC Sports Hall of Famer Kirk McLean Joins Promino Nutritional Sciences, Inc. as Brand Ambassador

BURLINGTON, ON, March 4, 2024 /CNW/ - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FRANKFURT:93X) (the "Company" or "Promino") is pleased to announce Hall of Famer Kirk Mclean will be joining the team as a Brand Ambassador. 

'Captain Kirk' is one of the most popular hockey players to ever play with the NHL's Vancouver Canucks. McLean was born June 26, 1966 in Scarborough, Ontario and played for four other National Hockey League teams during his 17 year professional career, including the New Jersey Devils, Carolina Hurricanes, Florida Panthers and New York Rangers. McLean played his junior hockey in the OHL with the Oshawa Generals before being drafted by New Jersey.  

Throughout his career, McLean was recognized as a respected player on and off the ice. He is best known for his 10 and a half seasons with the Canucks, during which time he was a finalist for two Vezina Trophies, named to two NHL All-Star Games and received Second All-Star team honours. McLean represented Canada in international competition once. 

On November 25, 2010 McLean was honored by the Vancouver Canucks as only the second inductee in the Canucks' RING OF HONOUR. In September 2011, his contributions to the game of hockey were once more recognized by the Vancouver Canucks and their Alumni organization, when he received the distinguished Jake Milford Award, as recognition for his life-long dedication. 

July, 2014 saw Kirk inducted into the BC Hockey Hall of Fame. Following an induction into the BC Sports Hall of Fame in 2021. 

Today, McLean lives in Vancouver where he's an active member of the Vancouver Canucks Alumni, lending his time to numerous community events plus working for the Vancouver Canucks as their Team Ambassador.  

"Over the years, I've seen many nutritional products making a lot of claims." explained Kirk Mclean, Brand Ambassador for Promino. "Promino is different, I was very impressed with the science behind the product, developed over 23 years and backed by 25 clinical studies, this patented formula is proven effective. I am happy to endorse a company and products that demonstrate such a high level of integrity and look forward to introducing them to a wider global audience."  

"I am thrilled to have Kirk join our team." stated Vito Sanzone, CEO of Promino Nutritional Sciences. "Attracting best-in-class athletes who love our products is a key part of our marketing initiatives. Our Brand Ambassadors will help promote our brand in various ways, including social media, TV, print, and radio advertisements and through personal appearances for meetings or tradeshows."

Over a period of 18 months as Brand Ambassador Mr. McLean will receive compensation 1,500,000 common shares of Promino.

Corporate and Fiscal Advisors

Promino also announces it has entered into a corporate advisor agreement with Crystal Carson dated effective December 1, 2023 (the "Carson Agreement"), a fiscal advisory agreement with Caerus Capital Partners Inc. ("Caerus") dated effective January 22, 2024 (the "Caerus Agreement") and corporate advisor agreement with Palmer Consulting Inc. ("Palmer") dated effective February 21, 2024 (the "Palmer Agreement"). Pursuant to the Carson Agreement, Ms. Carson will provide certain corporate advisory services to the Company in consideration for the issuance of 41,600 common shares of the Company to Ms. Carson each month, for up to an aggregate maximum of 500,000 shares during the initial 12 month term of the agreement. Pursuant to the Palmer Agreement, Palmer will provide certain corporate advisory services to the Company for an initial term of 18 months, in consideration for the issuance of up to an aggregate of 2,160,000 shares, with 1,000,000 shares issuable upon signing and an additional 290,000 shares issuable quarterly during the first year of the engagement. Pursuant to the Caerus Agreement, Caerus will provide certain fiscal advisory services to the Company in consideration for the issuance of an aggregate of up to 2,000,000 common shares of the Company to Caerus, with 400,000 shares issuable upon signing and an additional 400,000 shares issuable every three months thereafter during the initial 12 month term of the agreement. Each of the Carson Agreement, Caerus Agreement and Palmer Agreement can be terminated on 10 days written notice by either party. All securities issued under the Carson Agreement, Caerus Agreement and Palmer Agreement will be subject to a statutory hold period of four months and one day.

About Promino™ and Rejuvenate Muscle™

Promino™ is NSF Certified for Sport, which means it is free of banned substances and approved for use by all major sports leagues. Additionally, Promino invested in a rigorous flavoring process with a top tier U.S. flavor house responsible for creating the taste of several of North America's best-selling sports nutrition beverages. Followed by extensive in-market consumer testing, the Company will launch two refreshing fruit flavors in Q2 2024.

Promino™ and Rejuvenate™ utilize a patented formula from the University of Arkansas, led by Dr. Robert Wolfe and is the result of over USD $20 million in research over 23 years including extensive human clinical trials on muscle repair, recovery and muscle protein synthesis.

The patented essential amino acid blend, in the precise ratio to accelerate muscle protein synthesis, is fast-absorbing and provides the body with the building blocks of protein faster, without the excess calories, filler and carbohydrates of conventional whey or plant proteins. Promino™'s patented amino acid formula contains the essential building blocks of protein and are shown to be the highest quality protein source in the world based on the rising gold standard of protein quality – DIAAS – which measures the uptake of these key amino acids in the digestive tract. With a 321 DIAAS (Digestible Indispensable Amino Acid Score), Promino™ is superior to whey protein at 109.

Promino™ is more effective than whey protein at producing the desired results – with none of the fat, sugar, carbs or bloat. It is a significant step forward for pro and collegiate athletes.

About Promino

Promino is an innovative and research driven Canadian nutraceutical company specializing in the development of patented and science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's lead product, Rejuvenate™, is a patented proprietary formulation that is clinically proven to assist in the building, rebuilding, restoration and rejuvenation of natural muscle mass. Promino also offers Promino™, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury. Promino was founded in 2015 and is located in Burlington, Ontario.

To learn more about Promino, visit http://www.drinkpromino.com 

More information about Rejuvenate™ can be found https://www.rejuvenatemuscle.com

Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. All statements that address activities, events, or developments that the Company expects or anticipates will, or may, occur in the future, are forward-looking statements, including statements regarding: the Consolidation, including the anticipated timing of the Consolidation and the expected effect of the Consolidation on the outstanding share capital of the Company; and the Company's business prospects, future trends, plans and strategies. In some cases, forward looking statements are preceded by, followed by, or include words such as "may", "will," "would", "could", "should", "believes", "estimates", "projects", "potential", "expects", "plans", "anticipates", "continues", or the negative of those words or other similar or comparable words. In preparing the forward-looking statements in this news release, the Company has applied several material assumptions, including, but not limited to, that protein supplement market growth will continue as anticipated by the Company, and that general business and economic conditions will not change in a materially adverse manner. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

SOURCE Promino Nutritional Sciences Inc.